Johnson & Johnson Innovation-JJDC takes equity stake in Triastek

Bitget2026/10/14 12:17

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Johnson & Johnson Innovation-JJDC will make an equity investment in Triastek under a strategic oral medicines collaboration.
The deal pairs Johnson & Johnson drug development capabilities with Triastek’s 3D printing technology for oral delivery of peptides.
The companies entered a Collaboration and License Agreement through Janssen Pharmaceutica NV on Oct. 9, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson Innovation-JJDC Inc. published the original content used to generate this news brief on October 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Johnson & Johnson Innovation-JJDC takes equity stake in Triastek

You may also like

Crypto prices